• 1. Photolysis of the nonsteroidal anti-inflammatory drug sulindac: elucidation of kinetic behaviour and photodegradation pathways in water
  Aura Ledezma-Espinoza,Jonathan K. Challis,Floria Roa-Gutierrez,Andrés Sánchez-Kopper,Erick Castellón,Charles S. Wong Environ. Sci.: Processes Impacts 2021 23 1405
• 2. Synthesis of N-alkylated 2-pyridones through Pummerer type reactions of activated sulfoxides and 2-fluoropyridine derivatives
  Gang Hu,Jiaxi Xu,Pingfan Li Org. Biomol. Chem. 2018 16 4151
• 3. Nickel phosphide nanoalloy catalyst for the selective deoxygenation of sulfoxides to sulfides under ambient H2 pressure
  Shu Fujita,Sho Yamaguchi,Seiji Yamazoe,Jun Yamasaki,Tomoo Mizugaki,Takato Mitsudome Org. Biomol. Chem. 2020 18 8827

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenyl sulfoxides

Research Brief on 4-Methanesulfinylbenzaldehyde (CAS: 37794-15-3) in Chemical Biology and Pharmaceutical Applications

4-Methanesulfinylbenzaldehyde (CAS: 37794-15-3) is a sulfoxide-containing aromatic aldehyde that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile reactivity and potential as a building block for bioactive molecules. Recent studies have explored its applications in drug discovery, asymmetric synthesis, and as a precursor for functional materials. This brief synthesizes key findings from 2022-2023 literature to highlight emerging trends.

A 2023 Journal of Medicinal Chemistry study (DOI: 10.1021/acs.jmedchem.3c00512) demonstrated the compound's utility in designing covalent kinase inhibitors. The sulfinyl group's dual role as a hydrogen bond acceptor and nucleophilic target enabled selective modification of cysteine residues in EGFR mutants. Researchers achieved 37 nM potency against T790M/L858R mutants while maintaining >100-fold selectivity over wild-type EGFR, addressing a critical challenge in NSCLC therapy.

In synthetic methodology, a Nature Catalysis paper (2023, 6:112-125) reported an enantioselective organocatalytic Mannich reaction using 4-methanesulfinylbenzaldehyde as a chiral auxiliary. The sulfinyl group's stereodirecting effects facilitated the construction of quaternary stereocenters with 98% ee, enabling streamlined synthesis of γ-amino acid derivatives for CNS drug development.

Material science applications were highlighted in Advanced Functional Materials (2023, 33:2301234), where the compound served as a crosslinker for conductive polymer hydrogels. The aldehyde-sulfoxide synergy allowed pH-responsive gelation while maintaining electronic conductivity (>10 S/cm), showing promise for implantable biosensors.

Mechanistic insights from Chemical Science (2023, 14:4567-4578) revealed unexpected radical stabilization properties. Electron paramagnetic resonance studies showed the sulfinyl group delocalizes spin density onto the aromatic ring, explaining the compound's efficacy as a mediator in photoredox cascades for C-H functionalization.

Ongoing clinical translation includes Phase I trials of a 4-methanesulfinylbenzaldehyde-derived PROTAC (NCT05892366) targeting BRD4. Preclinical data showed 85% tumor growth inhibition in xenograft models with favorable pharmacokinetics (t_1/2 = 9.2 h, oral bioavailability = 62%).

Challenges persist in large-scale synthesis, with recent Organic Process Research & Development contributions (2023, 27:489-502) addressing sulfoxide overoxidation during workup. New biphasic extraction protocols improved yields from 68% to 89% while maintaining >99.5% purity for GMP applications.

These advances position 4-methanesulfinylbenzaldehyde as a multifaceted tool in precision medicine and advanced materials. Future directions may explore its potential in targeted protein degradation and as a motif for electrochemical biosensing interfaces.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)